Evidence map›Paper›PMID 25170305›Full record

ReviewInternational journal of biological sciences2014

Erythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid system.

Li Wang, Lijun Di, Constance Tom Noguchi

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in International journal of biological sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03060603 (Proliferative Effects of Erythropoietin on Human Endometrium), which is not on this map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03060603 completednot on this mapstarted 2017, after this paper: background citation

Proliferative Effects of Erythropoietin on Human Endometrium

TypeobservationalSponsorFatih Sultan Mehmet Training and Research HospitalRan2017 to 2018Enrolled14ConditionsAnemia, Endometrial DiseasesArmsErythropoietin
3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Erythropoietin treatment and the risk of hip fractures in hemodialysis patients.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2021
    Article
  15. Review
  16. Article
  17. Article
  18. Effects of Erythropoietin in White Adipose Tissue and Bone Microenvironment.Frontiers in cell and developmental biology · 2020
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Li Wang1. Faculty of Health Sciences, University of Macau, SAR of People's Republic of China.
Lijun Di1. Faculty of Health Sciences, University of Macau, SAR of People's Republic of China.
Constance Tom Noguchi2. Molecular Medicine Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, U.S.A.
University of Macau · MONational Institute of Diabetes and Digestive and Kidney Diseases · US

Funding

Erythropoietin receptor and glucose metabolismZIADK025102 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI NOGUCHI, CONSTANCE · 2009 to 2015
$3.5M
Role of erythropoietin in skeletal muscle and bone maintenance and repairZIADK025103 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI NOGUCHI, CONSTANCE · 2009 to 2015
$2.2M
6 · The paper itself

Abstract

Erythropoietin (EPO), the required cytokine for promoting the proliferation and differentiation of erythroid cells to stimulate erythropoiesis, has been reported to act as a pleiotropic cytokine beyond hematopoietic system. The various activities of EPO are determined by the widespread distribution of its cell surface EPO receptor (EpoR) in multiple tissues including endothelial, neural, myoblasts, adipocytes and other cell types. EPO activity has been linked to angiogenesis, neuroprotection, cardioprotection, stress protection, anti-inflammation and especially the energy metabolism regulation that is recently revealed. The investigations of EPO activity in animals and the expression analysis of EpoR provide more insights on the potential of EPO in regulating energy metabolism and homeostasis. The findings of crosstalk between EPO and some important energy sensors and the regulation of EPO in the cellular respiration and mitochondrial function further provide molecular mechanisms for EPO activity in metabolic activity regulation. In this review, we will summarize the roles of EPO in energy metabolism regulation and the activity of EPO in tissues that are tightly associated with energy metabolism. We will also discuss the effects of EPO in regulating oxidative metabolism and mitochondrial function, the interactions between EPO and important energy regulation factors, and the protective role of EPO from stresses that are related to metabolism, providing a brief overview of previously less appreciated EPO biological function in energy metabolism and homeostasis.

Indexed as

AnimalsCell DifferentiationEnergy MetabolismErythropoiesisErythropoietinHematopoietic SystemHumansErythropoietinerythroid systemErythropoietinpleiotropic cytokine

Identifiers

PMID25170305
PMCPMC4147225
OpenAlexW2118455831

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.